University of Limerick Institutional Repository

Can antigenic drift of SARS-CoV-2 spike protein jeopardize current vaccine development?

DSpace Repository

Show simple item record

dc.contributor.author Senanayake, Suranga L
dc.date.accessioned 2020-07-21T07:08:57Z
dc.date.available 2020-07-21T07:08:57Z
dc.date.issued 2020
dc.identifier.uri http://hdl.handle.net/10344/9015
dc.description peer-reviewed en_US
dc.description.abstract An effective vaccine against COVID-19 is widely considered the most promising exit strategy from the gravest pandemic in over a century. There were over 70 candidates employing diverse technology platforms as reported by the WHO in April 2020, most targeting the spike (S) protein/subunits of SARS-CoV-21 en_US
dc.language.iso eng en_US
dc.publisher ONMY Publishing Group en_US
dc.relation.ispartofseries American journal of Virology & Disease;2(2), pp. 01-02
dc.subject Avian Influenza en_US
dc.subject Steinerization en_US
dc.title Can antigenic drift of SARS-CoV-2 spike protein jeopardize current vaccine development? en_US
dc.type info:eu-repo/semantics/article en_US
dc.type.supercollection all_ul_research en_US
dc.type.supercollection ul_published_reviewed en_US
dc.rights.accessrights info:eu-repo/semantics/openAccess en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ULIR


Browse

My Account

Statistics